PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 162 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $130,000 | -77.7% | 12,047 | -19.9% | 0.12% | -64.1% |
| Q1 2019 | $583,000 | +48.3% | 15,031 | -22.1% | 0.33% | +58.2% |
| Q4 2018 | $393,000 | -28.9% | 19,288 | +59.9% | 0.21% | -13.7% |
| Q3 2018 | $553,000 | +65.1% | 12,063 | +330.8% | 0.24% | +153.7% |
| Q3 2017 | $335,000 | +47.6% | 2,800 | +7.7% | 0.10% | +21.8% |
| Q2 2017 | $227,000 | -65.3% | 2,600 | -87.8% | 0.08% | -77.3% |
| Q4 2016 | $654,000 | +69.9% | 21,300 | +62.6% | 0.34% | +33.9% |
| Q1 2016 | $385,000 | – | 13,100 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |